These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 18539226)

  • 41. Surgery for Trichiasis, Antibiotics to prevent Recurrence (STAR) Clinical Trial methodology.
    West ES; Alemayehu W; Munoz B; Melese M; Imeru A; West SK
    Ophthalmic Epidemiol; 2005 Aug; 12(4):279-86. PubMed ID: 16033749
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-effectiveness of trachoma control in seven world regions.
    Baltussen RM; Sylla M; Frick KD; Mariotti SP
    Ophthalmic Epidemiol; 2005 Apr; 12(2):91-101. PubMed ID: 16019692
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current status of trachoma elimination in Australia: making trachoma a history by 2020.
    Jung J; Rahman S; Rashid H; Khandaker G
    Infect Disord Drug Targets; 2014; 14(3):219-22. PubMed ID: 25944335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trachoma: global magnitude of a preventable cause of blindness.
    Mariotti SP; Pascolini D; Rose-Nussbaumer J
    Br J Ophthalmol; 2009 May; 93(5):563-8. PubMed ID: 19098034
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The SAFE strategy for the elimination of trachoma by 2020: will it work?
    Bailey R; Lietman T
    Bull World Health Organ; 2001; 79(3):233-6. PubMed ID: 11285668
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors for recurrence of postoperative trichiasis: implications for trachoma blindness prevention.
    Zhang H; Kandel RP; Sharma B; Dean D
    Arch Ophthalmol; 2004 Apr; 122(4):511-6. PubMed ID: 15078668
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Corneal blindness: a global perspective.
    Whitcher JP; Srinivasan M; Upadhyay MP
    Bull World Health Organ; 2001; 79(3):214-21. PubMed ID: 11285665
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Achieving trachoma control in Ghana after implementing the SAFE strategy.
    Yayemain D; King JD; Debrah O; Emerson PM; Aboe A; Ahorsu F; Wanye S; Ansah MO; Gyapong JO; Hagan M
    Trans R Soc Trop Med Hyg; 2009 Oct; 103(10):993-1000. PubMed ID: 19286239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mathematical Modelling of Trachoma Transmission, Control and Elimination.
    Pinsent A; Blake IM; Basáñez MG; Gambhir M
    Adv Parasitol; 2016; 94():1-48. PubMed ID: 27756453
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trachomatous trichiasis and its management in endemic countries.
    Rajak SN; Collin JR; Burton MJ
    Surv Ophthalmol; 2012; 57(2):105-35. PubMed ID: 22285842
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: the Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia.
    Stare D; Harding-Esch E; Munoz B; Bailey R; Mabey D; Holland M; Gaydos C; West S
    Ophthalmic Epidemiol; 2011 Feb; 18(1):20-9. PubMed ID: 21275593
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of three years of the SAFE strategy (Surgery, Antibiotics, Facial cleanliness and Environmental improvement) for trachoma control in five districts of Ethiopia hyperendemic for trachoma.
    Ngondi J; Gebre T; Shargie EB; Adamu L; Ejigsemahu Y; Teferi T; Zerihun M; Ayele B; Cevallos V; King J; Emerson PM
    Trans R Soc Trop Med Hyg; 2009 Oct; 103(10):1001-10. PubMed ID: 19178920
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Application of molecular tools in the control of blinding trachoma.
    Mabey D; Solomon AW
    Am J Trop Med Hyg; 2003 Nov; 69(5 Suppl):11-7. PubMed ID: 14692675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bacterial infection and trachoma in the gambia: a case control study.
    Burton MJ; Adegbola RA; Kinteh F; Ikumapayi UN; Foster A; Mabey DC; Bailey RL
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4440-4. PubMed ID: 17898263
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Trachoma is still a pediatric disease].
    Labetoulle M; Raymond J
    Arch Pediatr; 2005 Apr; 12 Suppl 1():S35-41. PubMed ID: 15893236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. WHO's mission for vision.
    Afr Health; 1998 Jul; 20(5):38. PubMed ID: 12294120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Innate immunity in ocular Chlamydia trachomatis infection: contribution of IL8 and CSF2 gene variants to risk of trachomatous scarring in Gambians.
    Natividad A; Hull J; Luoni G; Holland M; Rockett K; Joof H; Burton M; Mabey D; Kwiatkowski D; Bailey R
    BMC Med Genet; 2009 Dec; 10():138. PubMed ID: 20015396
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors for postsurgical trichiasis recurrence in a trachoma-endemic area.
    West ES; Mkocha H; Munoz B; Mabey D; Foster A; Bailey R; West SK
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):447-53. PubMed ID: 15671268
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blinding trachoma in the northern provinces of Vietnam--a cross sectional survey.
    Khandekar R; Nga NH; Mai P
    Ophthalmic Epidemiol; 2006 Jun; 13(3):183-9. PubMed ID: 16854772
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trachoma elimination, approaching 2020.
    Diab MM; Allen RC; Gawdat TI; Saif AS
    Curr Opin Ophthalmol; 2018 Sep; 29(5):451-457. PubMed ID: 29965850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.